Good post TP. With all of the recent discussions
Post# of 72440
[i]With all of the recent discussions about what some may perceive as glaring red flags, some perceive as trivial non-issues, and some are somewhere in between, it all just reiterates the importance of the Kevetrin trial for this company and investors alike. [/i]
I agree completely. Some of the issues brought up have been there for YEARS and are to me, a non issue but essential for Cellceutix to continue moving forward. Keep an eye on the linkedin connections, Menon has a habit of connecting, and one or more of the "new" connections just may end up being part of the BoD. :-)